← Leaderboards
Kwang-Soo Kim
Mc Lean Hospital (Belmont, Ma)
$20,694,978
Attributed
$27,319,090
Total exposure
15
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$27,319,090 · 15
By mechanism
R01$17,071,488 · 7
R24$3,357,716 · 1
P50$2,180,148 · 1
RC4$1,896,390 · 1
R21$1,503,700 · 3
R33$784,141 · 1
Top collaborators
- Sek Won Kong8 shared
- Jeffrey H Kordower5 shared
- Daniel G Anderson4 shared
- Klavs F Jensen4 shared
- Robert P Lanza1 shared
Most similar at Mc Lean Hospital (Belmont, Ma)
Same institution · by research overlap
- Rosario Sanchez-Pernaute$4,786,541
- Kai Christian Sonntag$1,985,794
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularCellsBaseDopaminergic NeuronNeuronsGene ExpressionTranscription FactorIn VitroIn VivoCell LineAffectParkinson DiseaseEmbryonic Stem CellResearch StudyGeneticMidbrain StructureCell TypeDisease ModelTissuesBrainBiologicalInduced Pluripotent Stem CellEmbryoAnimal Model
Grant awards (65)
Human iPSC-Based Personalized Cell Therapy of PD$689,100
R01 · FY2025 · NS · contact PI
Crosstalk Between Nurr1 and Risk Factors of Parkinson's Disease and its Regulation by Nurr1's Ligands$432,440
R01 · FY2025 · NS · contact PI
Human iPSC-Based Personalized Cell Therapy of PD$668,428
R01 · FY2024 · NS · contact PI
Crosstalk Between Nurr1 and Risk Factors of Parkinson's Disease and its Regulation by Nurr1's Ligands$419,469
R01 · FY2024 · NS · contact PI
Human iPSC-Based Personalized Cell Therapy of PD$705,100
R01 · FY2023 · NS · contact PI
Crosstalk Between Nurr1 and Risk Factors of Parkinson's Disease and its Regulation by Nurr1's Ligands$479,123
R01 · FY2023 · NS · contact PI
Crosstalk between Nurr1 and risk factors of Parkinson's disease and its regulation by Nurr1's ligands$525,507
R56 · FY2022 · NS · contact PI
Biorepository of iPSC lines from diverse rat strains for regenerative medicine research$801,204
R24 · FY2021 · OD · contact PI
Biorepository of iPSC lines from diverse rat strains for regenerative medicine research$801,204
R24 · FY2020 · OD · contact PI
Human iPSC-based personalized cell therapy of PD$591,114
R01 · FY2020 · NS · contact PI
Biorepository of iPSC lines from diverse rat strains for regenerative medicine research$800,146
R24 · FY2019 · OD · contact PI
Human iPSC-based personalized cell therapy of PD$647,507
R01 · FY2019 · NS · contact PI
Biorepository of iPSC lines from diverse rat strains for regenerative medicine research$239,194
R24 · FY2019 · OD · contact PI
Biorepository of iPSC lines from diverse rat strains for regenerative medicine research$715,968
R24 · FY2018 · OD · contact PI
Human iPSC-based personalized cell therapy of PD$644,754
R01 · FY2018 · NS · contact PI
Functional Roles of Nurr1 for Midbrain Dopamine Neurons in Health and Disease$345,625
R01 · FY2018 · NS · contact PI
Human iPSC-based personalized cell therapy of PD$647,555
R01 · FY2017 · NS · contact PI
Functional Roles of Nurr1 for Midbrain Dopamine Neurons in Health and Disease$345,625
R01 · FY2017 · NS · contact PI
Human iPSC-based personalized cell therapy of PD$660,673
R01 · FY2016 · NS · contact PI
High throughput microfluidic intracellular delivery platform$510,860
R01 · FY2016 · GM
Functional Roles of Nurr1 for Midbrain Dopamine Neurons in Health and Disease$345,625
R01 · FY2016 · NS · contact PI
Functional Roles of Nurr1 in AD Related Pathophysiology$197,500
R21 · FY2016 · AG · contact PI
High throughput microfluidic intracellular delivery platform$510,860
R01 · FY2015 · GM
Functional Roles of Nurr1 for Midbrain Dopamine Neurons in Health and Disease$345,625
R01 · FY2015 · NS · contact PI
Functional Roles of Nurr1 in AD Related Pathophysiology$237,000
R21 · FY2015 · AG · contact PI
High throughput microfluidic intracellular delivery platform$510,860
R01 · FY2014 · GM
Functional Roles of Nurr1 for Midbrain Dopamine Neurons in Health and Disease$345,625
R01 · FY2014 · NS · contact PI
Protein-induced human iPS cells for personalized cell therapy of PD$335,325
R01 · FY2014 · NS · contact PI
High throughput microfluidic intracellular delivery platform$522,336
R01 · FY2013 · GM
Protein-induced human iPS cells for personalized cell therapy of PD$326,858
R01 · FY2013 · NS · contact PI
Transcriptional regulatory cascade of midbrain dopamine neuron development by Pit$391,050
R01 · FY2012 · MH · contact PI
Optimal Generation and Characterization of iPS Cell Lines from Healthy and ADHD S$389,141
R33 · FY2012 · MH · contact PI
Protein-induced human iPS cells for personalized cell therapy of PD$338,713
R01 · FY2012 · NS · contact PI
Optimal Generation and Characterization of iPS Cell Lines from Healthy and ADHD S$395,000
R33 · FY2011 · MH · contact PI
Transcriptional regulatory cascade of midbrain dopamine neuron development by Pit$391,050
R01 · FY2011 · MH · contact PI
Protein-induced human iPS cells for personalized cell therapy of PD$338,713
R01 · FY2011 · NS · contact PI
Patient-specific and universal donor blood cell from protein-induced iPS cells$1,896,390
RC4 · FY2010 · HL · contact PI
Transcriptional regulatory cascade of midbrain dopamine neuron development by Pit$395,000
R01 · FY2010 · MH · contact PI
Protein-induced human iPS cells for personalized cell therapy of PD$345,625
R01 · FY2010 · NS · contact PI
Optimal Generation and Characterization of iPS Cell Lines from Healthy and ADHD S$236,332
R21 · FY2010 · MH · contact PI
Optimal Generation and Characterization of iPS Cell Lines from Healthy and ADHD S$157,219
R21 · FY2010 · MH · contact PI
Genetic Engineering of ES Cells towards Optimal Cell Transplantation for PD$490,272
P50 · FY2009 · NS · contact PI
Transcriptional regulatory cascade of midbrain dopamine neuron development by Pit$395,000
R01 · FY2009 · MH · contact PI
Optimal Generation and Characterization of iPS Cell Lines from Healthy and ADHD S$233,649
R21 · FY2009 · MH · contact PI
Genetic Engineering of ES Cells towards Optimal Cell Transplantation for PD$476,177
P50 · FY2008 · NS · contact PI
Genetic approach for transneuronal NA circuitry mapping$237,311
R01 · FY2008 · DC · contact PI
Genetic Engineering of ES Cells towards Optimal Cell Transplantation for PD$476,995
P50 · FY2007 · NS · contact PI
Mechanisms of TH and DBH gene expression$262,173
R01 · FY2007 · MH · contact PI
Genetic approach for transneuronal NA circuitry mapping$240,436
R01 · FY2007 · DC · contact PI
Genetic Engineering of ES Cells towards Optimal Cell Transplantation for PD$373,794
P50 · FY2006 · NS · contact PI
Mechanisms of TH and DBH gene expression$285,688
R01 · FY2006 · MH · contact PI
Genetic approach for transneuronal NA circuitry mapping$247,616
R01 · FY2006 · DC · contact PI
Genetic Engineering of ES Cells towards Optimal Cell Transplantation for PD$362,910
P50 · FY2005 · NS
Mechanisms of TH and DBH gene expression$333,941
R01 · FY2005 · MH
Genetic approach for transneuronal NA circuitry mapping$253,575
R01 · FY2005 · DC
Mechanisms of TH and DBH gene expression$332,451
R01 · FY2004 · MH
Genetic approach for transneuronal NA circuitry mapping$298,575
R01 · FY2004 · DC
DA-specific gene discovery and promoter engineering$197,500
R21 · FY2004 · NS
Mechanisms of TH and DBH gene expression$316,000
R01 · FY2003 · MH
DA-specific gene discovery and promoter engineering$197,500
R21 · FY2003 · NS
DA-specific gene discovery and promoter engineering$47,000
R21 · FY2003 · NS
Mechanisms of TH and DBH gene expression$38,445
R01 · FY2003 · MH
TRANSCRIPTIONAL MECHANISMS OF TH AND DBH GENE EXPRESSION$191,262
R01 · FY2002 · MH
TRANSCRIPTIONAL MECHANISMS OF TH AND DBH GENE EXPRESSION$235,692
R01 · FY2001 · MH
TRANSCRIPTIONAL MECHANISMS OF TH AND DBH GENE EXPRESSION$172,685
R01 · FY2000 · MH